Cannabinoid-based vaping products and supplement formulations reported by consumers to precipitate adverse effects

• NCJ Number: 304539
• Journal: Drug Testing and Analysis Volume: Online Issue: Special Issue Dated: March 2022
• Author(s): Alaina K. Holt; Kimberly N. Karin; Shelle N. Butler; Amanda R. Ferreira; Alex J. Krotulski; Justin L. Poklis; Michelle R. Peace
• Date Published: March 2022
• Length: 9 pages
• Grant Number(s): 2014-R2-CX-K010; 2016-DN-BX-0150; 2018-75-CX-0036; 2019-MU-MU-0007
• Sponsoring Agency: National Institute of Justice (NIJ)
• Corporate Author: Virginia Commonwealth University
• Publication Format: Article
• Publication Type: Research (Applied/Empirical)
• Language: English
• Country: United States of America

Annotation

Cannabinoid-based products submitted by consumers experiencing adverse effects were analyzed to identify and quantitate ingredients.

Abstract

Product testing identified several synthetic cannabinoids and products with inaccurate or incomplete labeling. (Publisher Abstract)